JANX
Janux Therapeutics (JANX)
$31
About Janux Therapeutics (JANX)
Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded by David Campbell in June 2017 and is headquartered in San Diego, CA.
Details
Daily high
$14.49
Daily low
$14.07
Price at open
$14.09
52 Week High
$61.59
52 Week Low
$13.76
Market cap
860.7M
Dividend yield
0.00%
Volume
1.5M
Avg. volume
3.4M
P/E ratio
-8.54
Janux Therapeutics News
Details
Daily high
$14.49
Daily low
$14.07
Price at open
$14.09
52 Week High
$61.59
52 Week Low
$13.76
Market cap
860.7M
Dividend yield
0.00%
Volume
1.5M
Avg. volume
3.4M
P/E ratio
-8.54